Malignant melanoma of the eyelid skin:

Similar documents
Histopathology of Melanoma

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

MALIGNANT MELANOMA OF THE HEEL

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Polypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern

Histopathology: skin pathology

Breslow Thickness and Clark Level Evaluation in Albanian Cutaneous Melanoma

Female 18. Deeply pigmented lesion on trunk.?warty naevus?seborrhoeic keratosis?malignant melanoma. The best diagnosis is:

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type

FORELIMB SWEAT GLAND ADENOCARCINOMA IN A CAT

Acral Melanoma in Japan

Pathology of the skin. 2nd Department of Pathology, Semmelweis University

World Articles of Ear, Nose and Throat Page 1

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG

Malignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha

Histopathological Study of Lacrimal Gland Tumors

Amelanotic melanoma of the skin detailed review of the problem

Among the benign intraepithelial melanocytic proliferations, Inflamed Conjunctival Nevi. Histopathological Criteria. Resident Short Reviews

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma

WHAT DOES THE PATHOLOGY REPORT MEAN?

Assisting diagnosis of melanoma through the noninvasive biopsy of skin lesions

Clinical Pathological Conference. Malignant Melanoma of the Vulva

Prognostic value of tumour thickness in cutaneous malignant melanoma

Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT

Protocol applies to melanoma of cutaneous surfaces only.

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)

Melanoma Update: 8th Edition of AJCC Staging System

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

Basaloid carcinoma of the anal canal

Nasal mucosal melanosis may act as a harbinger of melanoma: A case report

Interesting Case Series. Desmoplastic Melanoma

Lichenoid Tissue Reaction in Malignant Melanoma A Potential Diagnostic Pitfall

NAACCR Webinar Series 1

ORAL MELANOMA Definition Epidemiology Clinical Presentation

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

Periocular Malignancies

Conjunctival Melanoma: A New Clinical and Therapeutical Approach

Directly Coded Summary Stage Melanoma

Nasreen A. Syed, MD F.C. Blodi Eye Pathology Laboratory University of Iowa

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Epithelial Cancer- NMSC & Melanoma

SEBACEOUS NEOPLASMS. Dr. Prachi Saraogi Clinical Fellow in Dermatology

Ocular Neoplasia What s Common? What s New? Richard R Dubielzig

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

K Blessing, J J H Grant, D S A Sanders, M M Kennedy, A Husain, P Coburn

Case Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Journal of International Academy of Forensic Science & Pathology (JIAFP)

Growth rate of melanoma in vivo and correlation with dermatoscopic and dermatopathologic findings

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Disorders of Cell Growth & Neoplasia. Histopathology Lab

Melanoma Case Scenario 1

S everal morphological features are frequently used in the

Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases

Diagnostic Value of Fluorescence Method on Melanoma in Dogs

Management of pediatric melanocytic lesions

Type IV collagen and laminin staining patterns in benign

Melanoma Case Scenario 1

Basal cell carcinoma 5/28/2011

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

Michael T. Tetzlaff MD, PhD

1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.

Melanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018

Malignant Peripheral Nerve Sheath Tumor

Clinical and Pathological Features of Cutaneous Malignant Melanoma: A Retrospective Analysis of 124 Japanese Patients

Collaborative Stage for TNM 7 - Revised 07/14/2009 [ Schema ]

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone

Melanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU

Histopathology: Cervical HPV and neoplasia

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

Desmoplastic Melanoma: Clinical Behavior and Management Implications

Papillary Lesions of the breast

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

Changes in the normal anatomy. In some sections a fairly normal. (entropion). Obliteration of glands and occasionally a cyst were

Collaborative Staging Manual and Coding Instructions Part II: Primary Site Schema

Update on 8 th Edition Cutaneous AJCC Staging of Primary Cutaneous Melanoma. Michael T. Tetzlaff MD, PhD

PanMidlands Ocular Cancer Pathway March 2008 Approved by The Midland Oculoplastic Surgery Society

Melanoma: The Basics. What is a melanocyte?

Rebecca Vogel, PGY-4 March 5, 2012

Technicians & Nurses Program

Conflict of Interest 9/2/2014. Pathogenesis and Comparison of Atypical Spitz Nevi vs Benign Spitz, and Childhood Melanoma

Diagnostic problems in uterine smooth muscle tumors

1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma

For additional information on meeting the criteria for Mohs, see Appendix 2.

A clinicopathological study of nodular sclerosing Hodgkin's disease

COMBINED NEVI are composed

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

CPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.

NAACCR Hospital Registry Webinar Series

PRIMARY OCULAR CARUNCULAR BASAL CELL CARCINOMA IN A CHINESE PATIENT

Multiple Primary Melanoma in a Thai Male: A Case Report

Case Report A Case of Primary Submandibular Gland Oncocytic Carcinoma

Thin Melanoma. N Context. The incidence of malignant melanoma is

Transcription:

British Journal of Ophthalmology, 1985, 69, 180-186 Malignant melanoma of the eyelid skin: histopathology and behaviour A GARNER,' L KOORNNEEF,2 A LEVENE,3 AND J R 0 COLLIN4 From the 'Department of Pathology, Institute of Ophthalmology, University of London, 17-25 Cayton Street, London EC] V 9A T; the 2Orbital Centre, Academisch Medisch Centrum, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; the 'Department of Histopathology, the Royal Marsden Hospital, Fulham Road, London SW3 6JJ; and 4Moorfields Eye Hospital, City Road, London ECI V 9PD SUMMARY Histological sections from 24 patients with malignant melanoma of the eyelid skin were studied and correlated with clinical follow-up for an average of 8*6 years. There was an average post-treatment follow-up of 7.4 years with a cure rate of 78% in the superficial spreading group. The average follow-up in the nodular melanoma group was 9*4 years with a cure rate of 75%. Nodular melanoma patients with the lesion in the lid margin have a worse prognosis than those with the lesion on the eyelid skin. Malignant melanoma of the eyelids, apart from the conjunctival surface, accounts for about 1% of all eyelid tumours' and slightly less than 7% of cutaneous malignant melanoma in the head and neck region.2 Because of its rarity descriptions have been based. on the study of small groups or isolated cases, and it has been difficult to establish a comprehensive and representative picture of the histology and behaviour of malignant melanoma in this situation. In the following account we describe the prognosis and histopathology in 24 patients followed up for between three and 33 years. Patients and methods of the authors (RC). Patients who presented clinically with a flat lesion (Fig. 1) were most likely to have a superficial spreading malignant melanoma than were patients presenting with a bulky or marginal lesion (Fig. 2), who were more likely to have a nodular melanoma. In our series 21 patients had surgery, two had irradiation, and one both treatments. The type of surgery varied with the size of the lesion. The margins of the excised specimens were histologically clear in 22 patients. In two patients in whom clearance was incomplete a second surgical procedure was performed with complete removal of A total of 24 patients, for whom adequate follow-up information was available, were included in the series. Their ages ranged from 18 to 80 years, with a majority presenting in the 6th and 7th decades. Females (15) were affected slightly more commonly than males (9). More than half of the tumours were located on the eyelid margin, and a further half of these were unpigmented. The upper lid was affected in 16 patients the lower lid in eight. The distribution was equal in the medial and lateral areas of the eyelids. Although it was not possible to comment on the clinical presentation of the tumours because of the retrospective nature of the majority in this study, 25% of the patients were seen preoperatively by one Fig. 1 Case 8. Clinicalpicture ofasuperficial spreading Correspondence to Professor A Garner. malignant melanoma. 180

Malignant melanoma ofthe eyelid skin: histopathology and behaviour Fig. 2 Clinical appearance ofan unpigmented nodular melanoma oflid margin. the residual tumour. No figures are available on the number of patients who were subjected to a diagnostic as opposed to an excisional biopsy. Histological sections were examined from each of the 24 patients. The sections were drawn from the files of the Institute of Ophthalmology, London (21 cases), the Dutch Cancer Institute at the Antoni van Leeuwenhoek Ziekenhuis (two cases), and the Royal Marsden Hospital, London (one case). Representative haematoxylin and eosin stained sections, including bleached preparations, were reviewed by two of the authors (AG and AL) using diagnostic criteria as defined by Levene.3 Three categories of invasive melanoma were recognised for the purpose of classi- 181 Fig. 3 Case3. Superficial spreading malignant melanoma. Invasion by heavily pigmented, pleomorphic tumour cells is confined to the epidermis and superficialstroma. (Haematoxylin and eosin, x 160). fication: lentigo maligna melanoma, superficial spreading malignant melanoma, and nodular malignant melanoma.45 Fig. 4 Case 6. Superficial spreading malignant melanoma. The epidermis is infiltrated by clusters oflightly pigmented melanocytes with minor invasion of the dermis. (Haematoxylin and eosin, x 160).

182 Fig. 5 Case3. Superficial spreading malignant melanoma. The epidermis is infiltrated and partially destroyed by groups of tumour cells that have abundant cytoplasm containingfine melanin granules. (Haematoxylin and eosin, x400). Results HISTOPATHOLOGY Superficial spreading malignant melanoma was diagnosed in nine cases on the basis of intraepidermal Fig. 6 Case 10. Nodular malignant melanoma. There is minimal lateral spread ofa fairly discrete tumour that involves both the conjunctiva and skin at the lid margin. (Haematoxylin and eosin, xis)..::~~~~~~~~~~~~~~~~~~~~~~~~~~~~~... A Garner, L Koornneef, A Levene, andj R 0 Collin invasion not confined to the basal layer by cells with appreciable cytoplasm containing, in all but one instance, a light dusting with melanin (Figs. 3-5). There was variable stromal invasion, and the maximum thickness of the tumour ranged from 0-1 to

~~~~~~~~~~~~~~~~~~~~~~. Malignant melanoma ofthe eyelid skin: histopathology and behaviour 183 minimal evidence of junctional activity or lateral intraepidermal spread. The tumour appeared to have arisen in the region of the lid margin in four instances (Nos. 10, 12, 15, and 20) where the epidermis and conjunctival epithelium meet (Figs. 6 and 7). The maximum thickness of the tumo-urs varied considerably, from 1.2 to 3*9 mm (mean 2-38 mm). Cellular pleomorphism with variation in nuclear size, shape, and staining intensity was seen to a greater or lesser extent in all tumours, and in most the nucleoli were moderately or markedly conspicuous (Figs. 8-10). Mitotic figures were observed in all but three cases and in five exceeded an average of two per highpower field. The melanin content was variable, and five of the 12 cases appeared to be amelanotic. The available sections in three cases were inadequate to allow recognition of the histological type, though the cytological features and evidence of stromal infiltration were such as to justify the diagnosis of malignancy. No example of lentigo maligna melanoma was Fig. 7 Case 12. Nodular malignant melanoma. A welldefined pigmented tumour located at the eyelid margin. recognised. (Haematoxyli and eosin, x 14). BEHAVIOUR Superficial spreading malignant melanoma. Posttreatment follow-up covered an average of 7*4 yr, five 2-2 mm, mean 0-55 mm. In two cases (Nos. 2 and 7) the lesion was essentially in situ with minimal evidence of stromal invasion. Mitotic figures were of five years. There were two tumour-related deaths, of the nine patients being followed up for a minimum generally inconspicuous. after seven and 12 yr, respectively, both having In 12 cases the tumour was considered to be a distant metastases. nodular malignant melanoma in that there was Nodular malignant melanoma. The average length extensive invasion of the subepithelial stroma with of follow-up after treatment of the initial lesion was........0....s:...... x...; '- : Fig. 8 Case]]. Nodular malignantmelanoma. The tumour cells have generally abundant cytoplasm, contain varying amounts ofpigment and conspicuous nucleoli. (Haematoxylin and eosin, x 400).

184 Fig. 9 Case 13. Nodular malignant melanoma. There is necrosis ofthe overlying epidermis, and the pleomorphic tumour cells have large, hyperchromatic nuclei. (Haematoxylin and eosin, x 400). 9.4 yr, with all of the surviving cases being followed up for 5 yr or more. Of the 12 patients four died, with evidence of metastasis in three of them. The remaining death occurred a few hours after surgery for removal of a local recurrence. One of the patients who died underwent a block dissection of the neck for cervical lymph node metastasis one year after the initial excision, death from multiple metastasis Fig. 10 Case 19. Nodular malignant melanoma. Many ofthe cells are spindle-shaped and mitotic activity is evident. (Haematoxylin and eosin, x400). A Garner, L Koornneef, A Levene, andj R 0 Collin occurring some 10 yr later. In one surviving patient (No. 21) the initial removal was incomplete, and a second surgical excision was required six months afterwards: she is alive and well four years after the first operation. Unclassified malignant melanoma. The three patients in this group were followed up for 12, seven, and eight years respectively. The single fatality

Malignant melanoma ofthe eyelid skin: histopathology and behaviour Table 1 Histopathological details and response to treatment in malignant melanoma of the eyelid skin Case Age Sex Type Histology Initial Recur. Follow-up Comments no. therapy (yr) (yr) Thick- Melanin Mitoses Pleo- Nucleolus ness morphism (mm) atypia 1 52 F Superficial 0-4 + - + + Excision - Alive 3 2 58 F Spreading 0-1 + - + + n - Alive 4 In situ 3 62 F " 05 + - + + Irradiation Dead 7 Dead with metastases 4 61 M " - + - + + "idead 12 Thickness not measurable 5 69 F " 22 - + + + Excision - Alive 10 6 62 M " 0-5 + - + + " - Alive 3 7 37 F " 0.2 + + + + " - Alive 10 In situ withearly invasion 8 65 F " 0.3 + + + + " - Alive 4 9 40 M " 0-2 + - + + n - Alive 14 10 55 M Nodular 3-3 - + + + n - Dead 2 Metastases after after 1 12 yrs 11 65 F " 3.2 + + + + " 2 Alive 7 Initial removal incomplete 12 39 M " 29 - + + + " - Alive 17 13 50 F " >2-5 ± + + + " - Alive 7 14 24 F 1-4 - - + + " - Alive 14 15 35 M 1-7 + - + + " - Dead 5 Lymphnode and cerebral metastases 16 57 M 2-5 - + + + " - Dead li Block dissection 1971 (cervical node metastasis, died 1981) 17 43 F " 12 + - + + " - Alive 33 Evidence of preceding naevus 18 43 F " 1-5 - + + + n - Alive 6 19 18 F " 39 + + + + n - Alive 6 20 64 M " 14 + + + n I1 Dead I Died post-op. (recurrence) 21 68 M " 30 + + + + 1/2 Alive 4 Initial removal incomplete 22 80 F Unclassi - - + + + Excision/ Dead 12 Died natural fiable irradiation causes 23 69 F " <5-5 + + + + Excision - Alive 7 24 74 F " - - + + + " - Alive 8 concerned the first of them (No. 22), an 80-year-old female who died of natural causes at the age of 92 years. Findings in individual cases are given in Table 1. Discussion Dermatopathologists commonly distinguish three types of cutaneous malignant melanoma. In our series we identified the nodular and superficial spreading forms but not the melanoma arising from a Hutchinson's freckle (lentigo maligna). This is unlikely to be a significant omission, however, others having described both the preinvasive6 and invasive form7 of the latter variant in the eyelids. Superficial spreading malignant melanoma was 185 diagnosed in nine patients (37.5% of the total), which is below the 70% incidence cited for the skin in other sites.8 In two of these cases the proliferation was largely intraepithelial, with minor evidence of deep invasion. Although the intraepidermal component was pigmented in all but one case, the melanin content of the stromal component was usually less evident, while the cells in this region were often spindle-shaped. The overall survival in this group, i.e., two tumour-related deaths in nine patients followed up for three to 14 years, is comparable to the 31% mortality after 5 years pertaining to this type of melanoma in general.9 Nodular malignant melanoma was the most frequent variant in our series (50% of the total), which is considerably in excess of the 12% cited for

186 skin melanoma as a whole.9 "' In four patients the tumour appeared to have originated at the lid margin and proliferated to create a fairly discrete compact nodule, with variable cytological pleomorphism and a dearth of pigment: two of these cases died as a result of metastasis and one who is alive and well needed further treatment for a local recurrence. The fourth also suffered a local recurrence and died a few hours after surgery on this account. The prognosis for tumours of the nodular variety in other situations is generally worse than for other types of cutaneous melanoma, an overall five-year survival of 44% having been quoted.9 Consequently the 25% mortality (16.7% after five years) for the 12 patients with this type of melanoma in the eyelid, seven of whom have survived more than five years, compares favourably with nodular malignant melanoma presenting at other sites. Early diagnosis and treatment prompted by the conspicuous location of the tumour may be a factor in the relatively better prognosis. But it is possibly patients with a nodular lesion developing at the mucocutaneous lid margin who are at greatest risk, since two of four such cases have had a fatal outcome and a third developed a local recurrence, whereas only one of eight patients in whom the tumour was confined to the skin has died. The cause of this unexpected finditg is obscure, but specific aspects of eyelid anatomy-may be involved, particularly the presence of efferent blood and lymph vessels at the margin, together with repeated minor trauma occasioned by blinking. The prognosis of cutaneous malignant melanoma relates also to the depths of invasion.8 1112 A similar consideration applies to malignant melanoma of the conjunctiva, where a thickness of under 1-5 mm usually implies a favourable outcome after treata ment. '' The maximum tumour thicknesses in the four patients with a fatal outcome in whom it was possible to take measurements were 0-5, 3 3, 1*7, 2*5 mm respectively. There were, however, eight patients in whom the tumour measured 1-5 mm or more who were alive and well at the time of review. To some extent the curvature of the eyelid at the margin where it meets the conjunctiva makes it difficult to determine the point from which measurements of thickness should be made, but even with this allowance the impression gained is that, size for size, malignant melanoma of the eyelid skin has a slightly better prognosis than its counterpart elsewhere. Whether a grading based on the tissue level reached by the invading tumour is applicable to the eyelid is debatable, since the total dermis (both papillary and reticular) is exceptionally thin in this region, and a A Garner, L Koornneef, A Levene, andj R 0 Collin stage V melanoma on the Clark et al. "I scale would often be a much smaller lesion than such staging would represent in other parts of the integument. For this reason we have chosen to confine ourselves to simple thickness measurements. The generally good response to surgical excision suggests that this is the preferred treatment. Of the 21 patients with surgery three had a tumour related death, but both the patients treated with irradiation died with metastases. In none of the patients treated with primary surgery was there evidence of local recurrence. Only two patients developed cervical lymphnode metastases, one of them undergoing a cervical block dissection, but the other had cerebral metastasis diagnosed at the same time. Finally we consider that the possible late presentation of metastases means that this and any similar study must follow up patients for at least 15 years. The authors thank Miss G Chrysanthopoulou, Miss R Hart, Mrs P Goodwin, Dr J M Henk, P v Heerde, and Miss J A M Haages for their co-operation and aid in this study. We also thank the several unnamed surgeons for their unequivocal and prompt return of the questionnaires. References 1 Henkind P, Friedman A. Cancer of the lids and ocular adnexa. In: Andrade R, Gumport SL, Popkin GL. Cancer of the skin: biology, diagnosis, management. Philadelphia: Saunders, 1976; 13: 45-71. 2 Batsakis J. Tumors of the head and neck. Baltimore: Williams and Wilkins, 1974. 3 Levene A. On the histological diagnosis and prognosis of malignant melanoma. J Clin Pathol 1980; 33: 101-24. 4 McGovern VJ, Mihm MC, Bailly C, et al. The classification of malignant melanoma and its histologic reporting. Cancer 1973; 32: 1446-57. 5 Kopf AW, Bart RS, Rodriguez-Sains RS. Malignant melanoma: a review. J Dermatol Surg Oncol 1977; 3: 41-125. 6 Rodriguez-Sains RS, Jakobiec FA, Iwamoto T. Lentigo maligna of the lateral canthal skin. Ophthalmology 1981; 88: 1186-92. 7 Naidoff MA, Bernardino VB, Clark WH. Melanocytic Iesions of the cyclid skin. Am J Ophthalmol 1981; 82: 371-82. 8 Clark WA Jr, Ainsworth AM, Bernardino EA, et al. The developmental biology of primary human malignant melanomas. Semin Oncol 1975; 2: 83-103. 9 Kopf AW, Bart RS, Rodriguez-Sains RS, Ackerman AB. Malignant melanoma. Ncw York: Masson, 1979. 10 Clark WII, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behaviour of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705-26. 11 Breslow A. Tumor thickness, level of invasion and node dissection in stage I cutancous melanoma. Ann Surg 1975; 182: 572-5. 12 McGovern VJ. The classification of melanoma and its relationship with prognosis. Pathology 1970; 2: 85-98. 13 Silvers DN, Jakobiec FA, Freeman TR, Lefkowitch JH, Elie RC. Melanoma of the conjunctiva: a clinicopathologic study. In: Jakobiec FA, ed. Ocular and adnexal tumors. Birmingham, Ala: Aesculapius, 1978: 583-99. 14 Liesegang TJ, Campbell RJ. Mayo Clinic experience with conjunctival melanomas. Arch Ophthalmol 1980; 98: 1385-9.